Cathie Wood has emphasized the transformative potential of artificial intelligence in the field of multi-omics, predicting a comprehensive overhaul of the global healthcare system. According to Wood, AI-driven multi-omics can integrate various biological data levels, allowing for early disease detection before symptoms manifest. This technology is expected to significantly reduce drug development timelines and costs, accelerate the introduction of innovative therapies, and enhance healthcare system efficiency. Wood believes this technological advancement will shift the healthcare industry from a reactive treatment model to a proactive health management system, focusing on early prevention rather than passive treatment. This shift is anticipated to fundamentally change the operational dynamics of healthcare, driving significant industry upgrades.